Viewing Study NCT01067066


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2026-06-14 @ 9:48 PM
Study NCT ID: NCT01067066
Status: TERMINATED
Last Update Posted: 2017-07-21
First Post: 2010-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TPI 287 View
None microtubule inhibitor View
None Temozolomide View
None Temodar View
None cytotoxic agent View
None unresectable Stage III View
None Stage IV View
None Metastatic Melanoma View